Glucient SR 1000 mg prolonged-release tablet

Ország: Egyesült Királyság

Nyelv: angol

Forrás: myHealthbox

Vedd Meg Most

Letöltés Betegtájékoztató (PIL)
07-06-2024
Letöltés Termékjellemzők (SPC)
07-06-2024

Aktív összetevők:

metformin hydrochloride

Beszerezhető a:

Consilient Health Ltd.,

ATC-kód:

A10BA02

INN (nemzetközi neve):

metformin hydrochloride

Adagolás:

1000mg

Gyógyszerészeti forma:

Prolonged-release tablet

Az alkalmazás módja:

oral use

db csomag:

28, 30, 56, 60 & 100 prolonged-release tablets.

Recept típusa:

POM - Prescription Only Medicine

Gyártó:

McGregor Cory Limited

Terápiás csoport:

Oral blood glucose lowering drugs, biguanides

Terápiás javallatok:

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Glucient SR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Engedélyezési státusz:

Authorised

Engedély dátuma:

2015-12-17

Betegtájékoztató

                                READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU 
START TAKING THIS MEDICINE BECAUSE IT CONTAINS 
IMPORTANT INFORMATION FOR YOU. 
•  Keep this leaflet. You may need to read it 
again.
•  If you have any further questions, ask your 
doctor, or pharmacist.
•  This medicine has been prescribed for you 
only. Do not pass it on to others. It may harm 
them, even if their signs of illness are the same 
as yours.
•  If you get any side effects, talk to your doctor, 
or pharmacist. This includes any possible side 
effects not listed in this leaflet. See section 4.
IN THIS LEAFLET: 
1. WHAT GLUCIENT SR IS AND WHAT IS IT USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE    
  GLUCIENT SR
3. HOW TO TAKE GLUCIENT SR
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE GLUCIENT SR
6. CONTENTS OF THE PACK AND OTHER INFORMATION
 
1. WHAT GLUCIENT SR IS AND WHAT IS IT  
    USED FOR
Glucient SR prolonged release tablets contain 
the active ingredient metformin hydrochloride 
and belong to a group of medicines called 
biguanides, used in the treatment of diabetes 
Glucient SR is used for the treatment of Type 2 
(non-insulin dependant) diabetes mellitus when 
diet and exercise changes alone have not been 
enough to control blood glucose (sugar).
Insulin is a hormone that enables body tissues to 
take glucose from the blood and to use it for 
energy or for storage for future use. People with 
Type 2 diabetes do not make enough insulin in 
their pancreas or their body does not respond 
properly to the insulin it does make. This causes 
a build-up of glucose in the blood which can 
cause a number of serious long-term problems 
so it is important that you continue to take your 
medicine, even though you may not have any 
obvious symptoms. Glucient SR makes the body 
more sensitive to insulin and helps return to 
normal the way your body uses glucose.
Glucient SR is associated with either a stable 
body weight or modest weight loss.
Glucient SR Prolonged Release Tablets are 
specially made
                                
                                Olvassa el a teljes dokumentumot
                                
                            

Termékjellemzők

                                *OXFLHQW65PJSURORQJHGUHOHDVHWDEOHW
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG'HF_&RQVLOLHQW+HDOWK/WG
1DPHRIWKHPHGLFLQDOSURGXFW
*OXFLHQW65PJSURORQJHGUHOHDVHWDEOHW
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
(DFKSURORQJHGUHOHDVHWDEOHWFRQWDLQVPJPHWIRUPLQK\GURFKORULGHHTXLYDOHQWWRPJPHWIRUPLQ
(DFKSURORQJHGUHOHDVHWDEOHWFRQWDLQVXSWRPJVRGLXPPPRO
)RUDIXOOOLVWRIH[FLSLHQWVVHHVHFWLRQ
3KDUPDFHXWLFDOIRUP
3URORQJHGUHOHDVHWDEOHW
:KLWHWDEOHWVKDOORZFRQYH[GLPHQVLRQ[PPZLWKPDUNLQJ³65´RQRQHVLGHDQGZLWKRXWPDUNLQJRQWKH
RWKHUVLGH
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
7UHDWPHQWRIW\SHGLDEHWHVPHOOLWXVLQDGXOWVSDUWLFXODUO\LQRYHUZHLJKWSDWLHQWVZKHQGLHWDU\PDQDJHPHQWDQG
H[HUFLVHDORQHGRHVQRWUHVXOWLQDGHTXDWHJO\FDHPLFFRQWURO
*OXFLHQW65PD\EHXVHGDVPRQRWKHUDS\RULQFRPELQDWLRQZLWKRWKHURUDODQWLGLDEHWLFDJHQWVRUZLWKLQVXOLQ
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
_0RQRWKHUDS\DQGFRPELQDWLRQZLWKRWKHURUDODQWLGLDEHWLFDJHQWV_
‡*OXFLHQW65PJVKRXOGEHWDNHQRQFHGDLO\ZLWKWKHHYHQLQJPHDODWDPD[LPXPUHFRPPHQGHGGRVHRI
WDEOHWVSHUGD\
‡*OXFLHQW65PJLVLQWHQGHGDVDPDLQWHQDQFHWKHUDS\IRUSDWLHQWVFXUUHQWO\WUHDWHGZLWKHLWKHUPJRU
PJRIPHWIRUPLQK\GURFKORULGH2QVZLWFKWKHGDLO\GRVHRI*OXFLHQW65VKRXOGEHHTXLYDOHQWWRWKHFXUUHQWGDLO\GRVH
RIPHWIRUPLQK\GURFKORULGH
‡,QSDWLHQWVWUHDWHGZLWKPHWIRUPLQK\GURFKORULGHDWDGRVHDERYHPJGDLO\VZLWFKLQJWR*OXFLHQW65LVQRW
UHFRPPHQGHG
‡)RUSDWLHQWVQHZWRPHWIRUPLQK\GURFKORULGHWKHXVXDOVWDUWLQJGRVHRI*OXFLHQW65LVPJRQFHGDLO\JLYHQ
ZLWKWKHHYHQLQJPHDO$IWHUWRGD\VWKHGRVHVKRXOGEHDGMXVWHGRQWKHEDVLVRIEORRGJOXFRVHPHDVXUHPHQWV$
VORZLQFUHPHQWLQGRVHPD\LPSURYHJDVWURLQWHVWLQDOWROHUDELOLW\
‡,IJO\FDHPLFFRQWUROLVQRWDFKLHYHGRQRQFHGDLO\GRVLQJRI*OXFLHQW65DWDPD[LPXPGRVHRIPJDGD\WKHQD
WZLFHGDLO\GRVLQJVF
                                
                                Olvassa el a teljes dokumentumot